Prof. Mutlu ARAT

1: Bekoz H, Ozbalak M, Karadurmus N, Paydas S, Turker A, Toptas T, Tuglular TF, Altuntas F, Cakar MK, Sonmez M, Gulbas Z, Demir N, Kaynar L, Yildirim R, Karadogan I, Arat M, Kapucu I, Aslan NA, Ozkocaman V, Turgut M, Yuksel MK, Ozcan M, Hacioglu SK, Barista I, Demirkaya M, Saydam G, Toprak SK, Yilmaz M, Demirkol O, Ferhanoglu B. Nivolumab for relapsed or refractory Hodgkin lymphoma: real- life experience. Ann Hematol. 2020 Jun 7. doi: 10.1007/s00277-020-04077-4. Epub ahead of print. PMID: 32507911.

2: Nagler A, Dholaria B, Labopin M, Savani BN, Angelucci E, Koc Y, Arat M, Pioltelli P, Sica S, Gülbas Z, Tischer J, Bernasconi P, Pavlu J, Socié G, Blaise D, Rigacci L, Martino M, Diez-Martin JL, Perić Z, Giebel S, Mohty M. Bone marrow versus mobilized peripheral blood stem cell graft in T-cell-replete haploidentical transplantation in acute lymphoblastic leukemia. Leukemia. 2020 May 11. doi: 10.1038/s41375-020-0850-9. Epub ahead of print. PMID: 32393841.

3: Nagler A, Kanate AS, Labopin M, Ciceri F, Angelucci E, Koc Y, Gülbas Z, Arcese W, Tischer J, Pioltelli P, Ozdogu H, Afanasyev B, Wu D, Arat M, Peric Z, Giebel S, Savani B, Mohty M. Post-transplant cyclophosphamide versus anti- thymocyte globulin for graft-versus-host disease prevention in haploidentical transplantation for adult acute lymphoblastic leukemia. Haematologica. 2020 Apr 30:haematol.2020.247296. doi: 10.3324/haematol.2020.247296. Epub ahead of print. PMID: 32354866.

4: Penack O, Marchetti M, Ruutu T, Aljurf M, Bacigalupo A, Bonifazi F, Ciceri F, Cornelissen J, Malladi R, Duarte RF, Giebel S, Greinix H, Holler E, Lawitschka A, Mielke S, Mohty M, Arat M, Nagler A, Passweg J, Schoemans H, Socié G, Solano C, Vrhovac R, Zeiser R, Kröger N, Basak GW. Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation. Lancet Haematol. 2020 Feb;7(2):e157-e167. doi: 10.1016/S2352-3026(19)30256-X. PMID: 32004485.

5: Bazarbachi A, Labopin M, Angelucci E, Gülbas Z, Ozdogu H, Arat M, de Rosa L, Pastano R, Pioltelli P, Montserrat R, Martino M, Ciceri F, Koç Y, Socié G, Blaise D, Herrera C, Chalandon Y, Bernasconi P, Marotta G, Castagna L, McDonald A, Visani G, Carluccio P, Vitek A, Simand C, Afanasyev B, Rösler W, Diez-Martin JL, Nagler A, Brissot E, Giebel S, Mohty M. Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for T Cell Acute Lymphoblastic Leukemia: A Report from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party. Biol Blood Marrow Transplant. 2020 May;26(5):936-942. doi: 10.1016/j.bbmt.2020.01.003. Epub 2020 Jan 9. PMID: 31926364.

6. Bazarbachi A, Boumendil A, Finel H, Castagna L, Dominietto A, Blaise D, Diez-Martin JL, Tischer J, Gülbas Z, Wallet HL, Corral LL, Mohty M, Koc Y, Yakoub-Agha I, Schmid C, El Cheikh J, Arat M, Forcade E, Dreger P, Rocha V, García GG, Chalandon Y, Ferra C, Orvain C, Robinson S, Montoto S, Sureda A. Influence of donor type, stem cell source and conditioning on outcomes after haploidentical transplant for lymphoma - a LWP-EBMT study. Br J Haematol. 2020 Mar;188(5):745-756. doi: 10.1111/bjh.16182. Epub 2019 Sep 9. PMID: 31498883.

7: Mohty M, Malard F, Abecasis M, Aerts E, Alaskar AS, Aljurf M, Arat M, Bader P, Baron F, Basak G, Bazarbachi A, Blaise D, Ciceri F, Corbacioglu S, Dalle JH, Dignan F, Fukuda T, Huynh A, Kuball J, Lachance S, Lazarus H, Masszi T, Michallet M, Nagler A, NiChonghaile M, Okamoto S, Pagliuca A, Peters C, Petersen FB, Richardson PG, Ruutu T, Saber W, Savani BN, Soiffer R, Styczynski J, Wallhult E, Yakoub-Agha I, Duarte RF, Carreras E. Prophylactic, preemptive, and curative treatment for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a position statement from an international expert group. Bone Marrow Transplant. 2020 Mar;55(3):485-495. doi: 10.1038/s41409-019-0705-z. Epub 2019 Oct 1. PMID: 31576023; PMCID: PMC7051913.

8: Attal M, Richardson PG, Rajkumar SV, San-Miguel J, Beksac M, Spicka I, Leleu X, Schjesvold F, Moreau P, Dimopoulos MA, Huang JS, Minarik J, Cavo M, Prince HM, Macé S, Corzo KP, Campana F, Le-Guennec S, Dubin F, Anderson KC; ICARIA-MM study group. Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study. Lancet. 2019 Dec 7;394(10214):2096-2107. doi: 10.1016/S0140-6736(19)32556-5. Epub 2019 Nov 14. Erratum in: Lancet. 2019 Dec 7;394(10214):2072. PMID: 31735560.

9: Domingo-Domènech E, Boumendil A, Climent F, Sengeloev H, Wahlin B, Wattad W, Arat M, Finel H, Schapp N, Ganser A, Yeshurun M, Pavone V, Snowden J, Finke J, Montoto S, Sureda A, Dreger P; Lymphoma Working Party of the European Society for Blood and Marrow Transplantation. Autologous hematopoietic stem cell transplantation for relapsed/refractory systemic anaplastic large cell lymphoma. A retrospective analysis of the lymphoma working party (LWP) of the EBMT. Bone Marrow Transplant. 2020 Apr;55(4):796-803. doi: 10.1038/s41409-019-0734-7. Epub 2019 Nov 6. PMID: 31695174.

10: Carré M, Porcher R, Finke J, Ehninger G, Koster L, Beelen D, Ganser A, Volin L, Lozano S, Friis L, Michallet M, Tischer J, Olavarria E, Cascon MJP, Iacobelli S, Koc Y, Jindra P, Arat M, de Witte T, Yakoub Agha I, Kröger N, Robin M. Role of Age and Hematopoietic Cell Transplantation-Specific Comorbidity Index in Myelodysplastic Patients Undergoing an Allotransplant: A Retrospective Study from the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 2020 Mar;26(3):451-457. doi: 10.1016/j.bbmt.2019.10.015. Epub 2019 Oct 21. PMID: 31647984.

11: Halkes C, de Wreede LC, Knol C, Simand C, Aljurf M, Tbakhi A, Vazquez L, Bloor A, Wagner-Drouet E, Vural F, Bodova I, Isaksson C, Diaz MÁ, Gruhn B, Snowden J, Arat M, Bazarbachi A, Spilleboudt C, Kulagin A, Marsh JC, Passweg J, Risitano AM, Peffault de Latour R, Dufour C; European Society for Blood and Marrow Transplantation Severe Aplastic Anemia Working Party. Allogeneic stem cell transplantation for acquired pure red cell aplasia. Am J Hematol. 2019 Nov;94(11):E294-E296. doi: 10.1002/ajh.25609. Epub 2019 Sep 9. PMID: 31396977.

12: Radujkovic A, Dietrich S, Blok HJ, Nagler A, Ayuk F, Finke J, Tischer J, Mayer J, Koc Y, Sorà F, Passweg J, Byrne JL, Jindra P, Veelken JH, Socié G, Maertens J, Schaap N, Stadler M, Itälä-Remes M, Tholouli E, Arat M, Rocha V, Ljungman P, Yakoub-Agha I, Kröger N, Chalandon Y. Allogeneic Stem Cell Transplantation for Blast Crisis Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors: A Retrospective Study by the EBMT Chronic Malignancies Working Party. Biol Blood Marrow Transplant. 2019 Oct;25(10):2008-2016. doi: 10.1016/j.bbmt.2019.06.028. Epub 2019 Jul 1. PMID: 31271884.

13: Korkmaz S, Solmaz Medeni S, Demirkan F, Kalayoglu Besisik S, Altay Dadin S, Akgun Cagliyan G, Kabukcu Hacioglu S, Sari I, Goren Sahin D, Arat M, Dagdas S, Ozet G, Kutlu N, Karaagac Akyol T, Ozcebe OI, Uskudar Teke H, Kiper Unal D, Guner N, Tombak A, Celik H, Bay I, Kiki I, Ozgur G, Erkurt MA, Ozatli D, Meletli O, Demircioglu S, Demir C, Kurtoglu E, Vural F, Tobu M, Karakus A, Ayyildiz O, Dal MS, Afacan Ozturk B, Albayrak M, Ocakci S, Bolaman Z, Sonmez M, Karakus V, Gokmen Sevindik O, Berber I, Dogu MH, Gulturk E, Ulas T, Payzin B, Kuku I, Cagirgan S, Altuntas F. The Turkish experience with therapeutic plasma exchange: A national survey. Transfus Apher Sci. 2019 Jun;58(3):287-292. doi: 10.1016/j.transci.2019.04.015. Epub 2019 Apr 23. PMID: 31036516.

14: Passweg JR, Baldomero H, Basak GW, Chabannon C, Corbacioglu S, Duarte R, Kuball J, Lankester A, Montoto S, de Latour RP, Snowden JA, Styczynski J, Yakoub-Agha I, Arat M, Mohty M, Kröger N; European Society for Blood and Marrow Transplantation (EBMT). The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies. Bone Marrow Transplant. 2019 Oct;54(10):1575-1585. doi: 10.1038/s41409-019-0465-9. Epub 2019 Feb 6. PMID: 30728439; PMCID: PMC6957459.

15: Cesaro S, Crocchiolo R, Tridello G, Knelange N, Van Lint MT, Koc Y, Ciceri F, Gülbas Z, Tischer J, Afanasyev B, Bruno B, Castagna L, Blaise D, Mohty M, Irrera G, Diez-Martin JL, Pierelli L, Pioltelli P, Arat M, Delia M, Fagioli F, Ehninger G, Aljurf M, Carella AM, Ozdogu H, Mikulska M, Ljungman P, Nagler A, Styczynski J. Comparable survival using a CMV-matched or a mismatched donor for CMV+ patients undergoing T-replete haplo-HSCT with PT-Cy for acute leukemia: a study of behalf of the infectious diseases and acute leukemia working parties of the EBMT. Bone Marrow Transplant. 2018 Apr;53(4):422-430. doi: 10.1038/s41409-017-0016-1. Epub 2018 Jan 12. PMID: 29330396.

16: Goren Sahin D, Arat M. Peripheral blood stem cell collection for allogeneic hematopoietic stem cell transplantation: Practical implications after 200 consequent transplants. Transfus Apher Sci. 2017 Dec;56(6):800-803. doi: 10.1016/j.transci.2017.11.009. Epub 2017 Nov 8. PMID: 29162402.

17: Tekgündüz E, Arat M, Göker H, Özdoğu H, Kaynar L, Çağırgan S, Erkurt MA, Vural F, Kiki İ, Altuntaş F, Demirkan F; Turkish Society of Apheresis (TSA). Autologous hematopoietic progenitor cell mobilization and collection in adult patients presenting with multiple myeloma and lymphoma: A position-statement from the Turkish Society of Apheresis (TSA). Transfus Apher Sci. 2017 Dec;56(6):845-849. doi: 10.1016/j.transci.2017.11.025. Epub 2017 Nov 10. PMID: 29153306.

18: Tekgündüz E, Demirkan F, Vural F, Göker H, Özdoğu H, Kiki İ, Aydoğdu İ, Kaynar L, Erkurt MA, Çağırgan S, Beşışık S, Dağdaş S, Koca E, Kadıköylü G, Gündüz E, Yılmaz M, Beköz H, Ural AU, Baştürk A, Arat M, Albayrak M, Öztürk E, Akyol A, Bolaman AZ, Nevruz O, Özkan HA, Özgür G, Altuntaş F. Current practice of autologous hematopoietic progenitor cell mobilization in adult patients with multiple myeloma and lymphoma: The results of a survey from Turkish hematology research and education group (ThREG). Transfus Apher Sci. 2017 Dec;56(6):804-808. doi: 10.1016/j.transci.2017.11.010. Epub 2017 Nov 9. PMID: 29153305.

19: Beköz H, Karadurmuş N, Paydaş S, Türker A, Toptaş T, Fıratlı Tuğlular T, Sönmez M, Gülbaş Z, Tekgündüz E, Kaya AH, Özbalak M, Taştemir N, Kaynar L, Yıldırım R, Karadoğan I, Arat M, Pepedil Tanrıkulu F, Özkocaman V, Abalı H, Turgut M, Kurt Yüksel M, Özcan M, Doğu MH, Kabukçu Hacıoğlu S, Barışta I, Demirkaya M, Köseoğlu FD, Toprak SK, Yılmaz M, Demirkürek HC, Demirkol O, Ferhanoğlu B. Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience. Ann Oncol. 2017 Oct 1;28(10):2496-2502. doi: 10.1093/annonc/mdx341. PMID: 28961828.

20: DeFilipp Z, Duarte RF, Snowden JA, Majhail NS, Greenfield DM, Miranda JL, Arat M, Baker KS, Burns LJ, Duncan CN, Gilleece M, Hale GA, Hamadani M, Hamilton BK, Hogan WJ, Hsu JW, Inamoto Y, Kamble RT, Lupo-Stanghellini MT, Malone AK, McCarthy P, Mohty M, Norkin M, Paplham P, Ramanathan M, Richart JM, Salooja N, Schouten HC, Schoemans H, Seber A, Steinberg A, Wirk BM, Wood WA, Battiwalla M, Flowers ME, Savani BN, Shaw BE. Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT. Bone Marrow Transplant. 2017 Feb;52(2):173-182. doi: 10.1038/bmt.2016.203. Epub 2016 Aug 22. PMID: 27548466; PMCID: PMC5288134.

21: Efe İris N, Diz-Küçükkaya R, Arat M, Eriş Z. Bullous Pyoderma Gangrenosum in a Patient with Acute Myelogenous Leukemia as a Pathergic Reaction after Bone Marrow Biopsy. Turk J Haematol. 2017 Dec 1;34(4):350-351. doi: 10.4274/tjh.2016.0096. Epub 2016 Jun 17. PMID: 27313098; PMCID: PMC5774376.

22: Efe İris N, Güvenç S, Özçelik T, Demirel A, Koçulu S, Çevik E, Arat M. Successful Treatment of Disseminated Fusariosis with the Combination of Voriconazole and Liposomal Amphotericin B. Turk J Haematol. 2016 Dec 1;33(4):363-364. doi: 10.4274/tjh.2016.0128. Epub 2016 Jun 17. PMID: 27311328; PMCID: PMC5204201.

23: DeFilipp Z, Duarte RF, Snowden JA, Majhail NS, Greenfield DM, Miranda JL, Arat M, Baker KS, Burns LJ, Duncan CN, Gilleece M, Hale GA, Hamadani M, Hamilton BK, Hogan WJ, Hsu JW, Inamoto Y, Kamble RT, Lupo-Stanghellini MT, Malone AK, McCarthy P, Mohty M, Norkin M, Paplham P, Ramanathan M, Richart JM, Salooja N, Schouten HC, Schoemans H, Seber A, Steinberg A, Wirk BM, Wood WA, Battiwalla M, Flowers MED, Savani BN, Shaw BE; CIBMTR Late Effects and Quality of Life Working Committee; EBMT Complications and Quality of Life Working Party. Metabolic Syndrome and Cardiovascular Disease after Hematopoietic Cell Transplantation: Screening and Preventive Practice Recommendations from the CIBMTR and EBMT. Biol Blood Marrow Transplant. 2016 Aug;22(8):1493-1503. doi: 10.1016/j.bbmt.2016.05.007. Epub 2016 May 14. PMID: 27184625; PMCID: PMC4949101.

24: Mohty M, Malard F, Abecassis M, Aerts E, Alaskar AS, Aljurf M, Arat M, Bader P, Baron F, Bazarbachi A, Blaise D, Ciceri F, Corbacioglu S, Dalle JH, Dignan F, Fukuda T, Huynh A, Masszi T, Michallet M, Nagler A, NiChonghaile M, Okamoto S, Pagliuca A, Peters C, Petersen FB, Richardson PG, Ruutu T, Savani BN, Wallhult E, Yakoub-Agha I, Duarte RF, Carreras E. Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation. Bone Marrow Transplant. 2016 Jul;51(7):906-12. doi: 10.1038/bmt.2016.130. Epub 2016 May 16. PMID: 27183098; PMCID: PMC4935979.

25: Özen M, Üstün C, Öztürk B, Topçuoğlu P, Arat M, Gündüz M, Atilla E, Bolat G, Arslan Ö, Demirer T, Akan H, İlhan O, Beksaç M, Gürman G, Özcan M. Allogeneic Transplantation in Chronic Myeloid Leukemia and the Effect of Tyrosine Kinase Inhibitors on Survival: A Quasi-Experimental Study. Turk J Haematol. 2017 Mar 1;34(1):16-26. doi: 10.4274/tjh.2015.0346. Epub 2016 Apr 18. PMID: 27094579; PMCID: PMC5451684.

26: Göksoy HS, Arat M. The use of second allogeneic hematopoietic stem cell transplantation for hematologic malignancies relapsed after the first: Does it worth to do? Transfus Apher Sci. 2016 Feb;54(1):91-8. doi: 10.1016/j.transci.2016.01.020. Epub 2016 Feb 26. PMID: 26976480.

27: Tekgündüz E, Şencan İ, Kapuağası A, Ünal D, Öztürk M, Gümüş E, Göker H, Tavil EB, Ertem M, Çetin M, Arat M, Soysal T, Karakaşlı O, Sur HY, Yeşilipek A, Ferhanoğlu B, Uçkan D, İlhan O, Altuntaş F. Hematopoietic cell transplantation activity of Turkey in 2014: Ongoing increase in HCT rates. Transfus Apher Sci. 2016 Feb;54(1):53-9. doi: 10.1016/j.transci.2016.01.013. Epub 2016 Jan 11. PMID: 26899916.

28: Fioredda F, Iacobelli S, van Biezen A, Gaspar B, Ancliff P, Donadieu J, Aljurf M, Peters C, Calvillo M, Matthes-Martin S, Morreale G, van 't Veer- Tazelaar N, de Wreede L, Al Seraihy A, Yesilipek A, Fischer A, Bierings M, Ozturk G, Smith O, Veys P, Ljungman P, Peffault de Latour R, Sánchez de Toledo Codina J, Or R, Ganser A, Afanasyev B, Wynn R, Kalwak K, Marsh J, Dufour C; Severe Aplastic Anemia the Inborn Error, and the Pediatric Disease Working Parties of the European Society for Blood and Bone Marrow Transplantation (EBMT) and Stem Cell Transplant for Immunodeficiencies in Europe (SCETIDE). Stem cell transplantation in severe congenital neutropenia: an analysis from the European Society for Blood and Marrow Transplantation. Blood. 2015 Oct 15;126(16):1885-92; quiz 1970. doi: 10.1182/blood-2015-02-628859. Epub 2015 Jul 16. PMID: 26185129.

29: Mohty M, Malard F, Abecassis M, Aerts E, Alaskar AS, Aljurf M, Arat M, Bader P, Baron F, Bazarbachi A, Blaise D, Ciceri F, Corbacioglu S, Dalle JH, Duarte RF, Fukuda T, Huynh A, Masszi T, Michallet M, Nagler A, NiChonghaile M, Pagluica T, Peters C, Petersen FB, Richardson PG, Ruutu T, Savani BN, Wallhult E, Yakoub- Agha I, Carreras E. Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives-a position statement from the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant. 2015 Jun;50(6):781-9. doi: 10.1038/bmt.2015.52. Epub 2015 Mar 23. PMID: 25798682; PMCID: PMC4456788.

30: Lawitschka A, Faraci M, Yaniv I, Veys P, Bader P, Wachowiak J, Socie G, Aljurf MD, Arat M, Boelens JJ, Duarte R, Tichelli A, Peters C. Paediatric reduced intensity conditioning: analysis of centre strategies on regimens and definitions by the EBMT Paediatric Diseases and Complications and Quality of Life WP. Bone Marrow Transplant. 2015 Apr;50(4):592-7. doi: 10.1038/bmt.2014.306. Epub 2015 Jan 26. PMID: 25621804.

31: Akan H, Ongören Aydın S, Saltoğlu N, Cağatay A, Akalın H, Arat M, Ali R, Kalayoğlu-Beşışık S, Demir AM. Recommendations for the Treatment of Invasive Fungal Infections in Hematological Malignancies: A Critical Review of Evidence and Turkish Expert Opinion (TEO-1). Turk J Haematol. 2014 Jun;31(2):111-20. doi: 10.4274/tjh.2014.0103. Epub 2014 Jun 10. PMID: 25035667; PMCID: PMC4102037.

32: Bakanay SM, Kaygusuz G, Topçuoğlu P, Sengül S, Tunçalı T, Keven K, Kuzu I, Uysal A, Arat M. Epstein-barr virus-negative post-transplant lymphoproliferative diseases: three distinct cases from a single center. Turk J Haematol. 2014 Mar;31(1):79-83. doi: 10.4274/Tjh.2012.0010. Epub 2014 Mar 5. PMID: 24764734; PMCID: PMC3996636.

33: Passweg JR, Baldomero H, Peters C, Gaspar HB, Cesaro S, Dreger P, Duarte RF, Falkenburg JH, Farge-Bancel D, Gennery A, Halter J, Kröger N, Lanza F, Marsh J, Mohty M, Sureda A, Velardi A, Madrigal A; European Society for Blood and Marrow Transplantation EBMT. Hematopoietic SCT in Europe: data and trends in 2012 with special consideration of pediatric transplantation. Bone Marrow Transplant. 2014 Jun;49(6):744-50. doi: 10.1038/bmt.2014.55. Epub 2014 Mar 17. PMID: 24637898; PMCID: PMC4051369.

34: Bilgin AU, Topcuoğlu P, Sancak T, Konuk N, Arat M. Intramesenteric steroid treatment for steroid- refractory gastrointestinal graft versus host disease. Turk J Haematol. 2012 Dec;29(4):409-12. doi: 10.5505/tjh.2012.57855. Epub 2012 Dec 5. PMID: 24385731; PMCID: PMC3781620.

35: Bakanay ŞM, Bilgin AU, Bektaş M, Idilman R, Erden E, Arat M, Arslan Ö. Vanishing bile duct syndrome after allogeneic bone marrow transplantation: is it the end of the road? Turk J Gastroenterol. 2013;24(4):359-62. doi: 10.4318/tjg.2013.0604. PMID: 24254270.

36: Bozdag SC, Topcuoglu P, Kuzu I, Arat M. Acute lymphoblastic leukemia during enzyme replacement therapy in type 1 Gaucher's disease. Clin Adv Hematol Oncol. 2013 Apr;11(4):251-2. PMID: 23604243.

37: Tichelli A, Labopin M, Rovó A, Badoglio M, Arat M, van Lint MT, Lawitschka A, Schwarze CP, Passweg J, Socié G. Increase of suicide and accidental death after hematopoietic stem cell transplantation: a cohort study on behalf of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Cancer. 2013 Jun 1;119(11):2012-21. doi: 10.1002/cncr.27987. Epub 2013 Mar 19. PMID: 23512286; PMCID: PMC3698695.

38: Rovó A, Aljurf M, Chiodi S, Spinelli S, Salooja N, Sucak G, Hunter A, Kim TS, Socié G, van Lint MT, Passweg JR, Arat M, Badoglio M, Tichelli A. Paternity wishes in long-term survivors after allogeneic hematopoietic SCT. A study of the late effects working party of the EBMT. Bone Marrow Transplant. 2013 Jun;48(6):878-9. doi: 10.1038/bmt.2012.255. Epub 2013 Jan 7. PMID: 23292242.

39: Efe Iris N, Sayıner H, Yildirmak T, Simsek F, Arat ME. Vancomycin-resistant Enterococcus carrier status in the reanimation units and related risk factors. Am J Infect Control. 2013 Mar;41(3):261-2. doi: 10.1016/j.ajic.2012.04.331. Epub 2012 Oct 13. PMID: 23069738.

40: Rovó A, Aljurf M, Chiodi S, Spinelli S, Salooja N, Sucak G, Hunter A, Kim TS, Socié G, van Lint MT, Passweg JR, Arat M, Badoglio M, Tichelli A; Late Effects Working Party of the EBMT. Ongoing graft-versus-host disease is a risk factor for azoospermia after allogeneic hematopoietic stem cell transplantation: a survey of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation. Haematologica. 2013 Mar;98(3):339-45. doi: 10.3324/haematol.2012.071944. Epub 2012 Aug 28. PMID: 22929982; PMCID: PMC3659920.

41: Gürgan CA, Özcan M, Karakuş Ö, Zincircioğlu G, Arat M, Soydan E, Topcuoglu P, Gürman G, Bostancı HS. Periodontal status and post-transplantation complications following intensive periodontal treatment in patients underwent allogenic hematopoietic stem cell transplantation conditioned with myeloablative regimen. Int J Dent Hyg. 2013 May;11(2):84-90. doi: 10.1111/j.1601-5037.2012.00550.x. Epub 2012 Apr 9. PMID: 22487659.

42: Yegin ZA, Arat M. A survey of hematologists on compulsory health service in Turkey. Turk J Haematol. 2011 Dec 5;28(4):335-6. English. doi: 10.5152/tjh.2011.91. PMID: 27264593.

43: Topcuoglu P, Arat M, Ozcan M, Arslan O, Ilhan O, Beksac M, Gurman G. Case- matched comparison with standard versus reduced intensity conditioning regimen in chronic myeloid leukemia patients. Ann Hematol. 2012 Apr;91(4):577-86. doi: 10.1007/s00277-011-1349-2. Epub 2011 Oct 5. PMID: 21971669.

44: Idilman R, Arat M. Evaluation and management of hepatitis B virus infection in hematopoietic stem cell transplantation: before and after transplantation. Expert Rev Anti Infect Ther. 2011 Aug;9(8):641-52. doi: 10.1586/eri.11.79. PMID: 21819330.

45: Gunay-Aygun M, Falik-Zaccai TC, Vilboux T, Zivony-Elboum Y, Gumruk F, Cetin M, Khayat M, Boerkoel CF, Kfir N, Huang Y, Maynard D, Dorward H, Berger K, Kleta R, Anikster Y, Arat M, Freiberg AS, Kehrel BE, Jurk K, Cruz P, Mullikin JC, White JG, Huizing M, Gahl WA. NBEAL2 is mutated in gray platelet syndrome and is required for biogenesis of platelet α-granules. Nat Genet. 2011 Jul 17;43(8):732-4. doi: 10.1038/ng.883. PMID: 21765412; PMCID: PMC3154019.

46: Idilman R, Bozkus Y, Seval G, Mizrak D, Cinar K, Ustun Y, Bektas M, Arat M, Akbulut H, Doganay B, Ozden A. Lymphoproliferative disorders in individuals with chronic hepatitis B and C in the Turkish population. J Med Virol. 2011 Jun;83(6):974-80. doi: 10.1002/jmv.21747. PMID: 21503909.

47: Solh M, Arat M, Cao Q, Majhail NS, Weisdorf D. Late-onset noninfectious pulmonary complications in adult allogeneic hematopoietic cell transplant recipients. Transplantation. 2011 Apr 15;91(7):798-803. doi: 10.1097/TP.0b013e31820c85fa. PMID: 21403586.

48: Tichelli A, Rovó A, Passweg J, Schwarze CP, Van Lint MT, Arat M, Socié G; Late Effects Working Party of the European Group for Blood and Marrow Transplantation. Late complications after hematopoietic stem cell transplantation. Expert Rev Hematol. 2009 Oct;2(5):583-601. doi: 10.1586/ehm.09.48. PMID: 21083023.

49: Arat M, Ozsan GH, Yenerel MN, Cetin M, Ozcan M. 2nd International Congress on Leukemia, Lymphoma and Myeloma. Expert Rev Hematol. 2009 Oct;2(5):509-12. doi: 10.1586/ehm.09.50. PMID: 21083016.

50: Kabaçam G, Kabaçam G, Topçuoğlu P, Kuzu I, Arat M. Enzyme replacement therapy in type 1 Gaucher disease and a review of the literature. Turk J Haematol. 2010 Sep 5;27(3):190-5. English. doi: 10.5152/tjh.2010.27. PMID: 27263604.

51: Gunay-Aygun M, Zivony-Elboum Y, Gumruk F, Geiger D, Cetin M, Khayat M, Kleta R, Kfir N, Anikster Y, Chezar J, Arcos-Burgos M, Shalata A, Stanescu H, Manaster J, Arat M, Edwards H, Freiberg AS, Hart PS, Riney LC, Patzel K, Tanpaiboon P, Markello T, Huizing M, Maric I, Horne M, Kehrel BE, Jurk K, Hansen NF, Cherukuri PF, Jones M, Cruz P, Mullikin JC, Nurden A, White JG, Gahl WA, Falik-Zaccai T. Gray platelet syndrome: natural history of a large patient cohort and locus assignment to chromosome 3p. Blood. 2010 Dec 2;116(23):4990-5001. doi: 10.1182/blood-2010-05-286534. Epub 2010 Aug 13. PMID: 20709904; PMCID: PMC3012593.

52: Şanlı H, Akay BN, Soydan E, Koçyiğit P, Arat M, İlhan O. Clinical Aspects Of Sclerodermatous Type Graft-Versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation. Turk J Haematol. 2010 Jun 5;27(2):91-8. English. doi: 10.5152/tjh.2010.06. PMID: 27263450.

53: Akay BN, Sanli H, Topcuoglu P, Arat M, Akyol A. Nailfold capillary abnormalities are prevalent in sclerodermoid graft-versus-host disease and readily detected with dermatoscopy. Br J Dermatol. 2010 May;162(5):1076-82. doi: 10.1111/j.1365-2133.2010.09667.x. Epub 2010 Mar 5. PMID: 20222922.

54: Kurt RA, Yalçindag N, Atilla H, Arat M. Topical cyclosporine-A in dry eye associated with chronic graft versus host disease. Ann Ophthalmol (Skokie). 2009 Fall-Winter;41(3-4):166-9. PMID: 20214049.

55: Gratwohl A, Stern M, Brand R, Apperley J, Baldomero H, de Witte T, Dini G, Rocha V, Passweg J, Sureda A, Tichelli A, Niederwieser D; European Group for Blood and Marrow Transplantation and the European Leukemia Net. Risk score for outcome after allogeneic hematopoietic stem cell transplantation: a retrospective analysis. Cancer. 2009 Oct 15;115(20):4715-26. doi: 10.1002/cncr.24531. PMID: 19642176.

56: Ozcelik T, Topcuoglu P, Beksac M, Ozcan M, Arat M, Biyikli Z, Bakanay SM, Ilhan O, Gurman G, Arslan O, Demirer T. Mobilization of PBSCs with chemotherapy and recombinant human G-CSF: a randomized evaluation of early vs late administration of recombinant human G-CSF. Bone Marrow Transplant. 2009 Dec;44(12):779-83. doi: 10.1038/bmt.2009.161. Epub 2009 Jul 13. PMID: 19597420.

57: Akar AR, Durdu S, Arat M, Kilickap M, Kucuk NO, Arslan O, Kuzu I, Ozyurda U. Five-year follow-up after transepicardial implantation of autologous bone marrow mononuclear cells to ungraftable coronary territories for patients with ischaemic cardiomyopathy. Eur J Cardiothorac Surg. 2009 Oct;36(4):633-43. doi: 10.1016/j.ejcts.2009.04.045. Epub 2009 Jun 12. PMID: 19524451.

58: Daikeler T, Hügle T, Farge D, Andolina M, Gualandi F, Baldomero H, Bocelli- Tyndall C, Brune M, Dalle JH, Urban C, Ehninger G, Gibson B, Linder B, Lioure B, Marmont A, Matthes-Martin S, Nachbaur D, Schuetz P, Tyndall A, van Laar JM, Veys P, Saccardi R, Gratwohl A; Working Party Autoimmune Diseases of the EBMT. Allogeneic hematopoietic SCT for patients with autoimmune diseases. Bone Marrow Transplant. 2009 Jul;44(1):27-33. doi: 10.1038/bmt.2008.424. Epub 2009 Jan 12. Erratum in: Bone Marrow Transplant. 2009 Jul;44(1):67. Urban, C [added]. PMID: 19139739.

59: Ozden A, Süleyman Z, Seven G, Arat M, Akin A, Sener O, Kuzu I, Keven K, Ensari A, Erden A, Tan E. POEMS syndrome: a case report. Turk J Gastroenterol. 2008 Dec;19(4):276-80. PMID: 19119489.

60: Gratwohl A, Baldomero H, Frauendorfer K, Niederwieser D; Joint Accreditation Committee of the International Society for Cellular Therapy ISCT; European Group for Blood and Marrow Transplantation EMBT (JACIE). Why are there regional differences in stem cell transplantation activity? An EBMT analysis. Bone Marrow Transplant. 2008 Aug;42 Suppl 1:S7-S10. doi: 10.1038/bmt.2008.104. PMID: 18724308.

61: Arat M, Arpaci F, Ertem M, Gürman G; Turkish Transplant Registry. Turkish Transplant Registry: a comparative analysis of national activity with the EBMT European Activity Survey. Bone Marrow Transplant. 2008 Aug;42 Suppl 1:S142-S145. doi: 10.1038/bmt.2008.144. PMID: 18724290.

62: Arat M, Idilman R. Hepatic complications of allogeneic hematopoietic cell transplantation. Turk J Haematol. 2008 Sep 5;25(3):111-23. English. PMID: 27264702.

63: Soydan E, Topcuoglu P, Dalva K, Arat M. The impact of methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism on transplant-related variables after allogeneic hematopoietic cell transplantation in patients receiving MTX as GVHD prophylaxis. Bone Marrow Transplant. 2008 Sep;42(6):429-30. doi: 10.1038/bmt.2008.184. Epub 2008 Jun 30. PMID: 18587432.

64: Tichelli A, Passweg J, Wójcik D, Rovó A, Harousseau JL, Masszi T, Zander A, Békássy A, Crawley C, Arat M, Sica S, Lutz P, Socié G; EBMT Late Effects Working Party. Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation. Haematologica. 2008 Aug;93(8):1203-10. doi: 10.3324/haematol.12949. Epub 2008 Jun 12. PMID: 18556401.

65: Bakanay ŞM, Topçuoğlu P, Uğur Bilgin A, Yararbaş K, Berker Karaüzüm S, Özcan M, Arat M, Ündar L, Ilhan O. Clonal evolution of monosomy 7 in acquired severe aplastic anemia: Two cases treated with allogeneic hematopoietic stem cell transplantation. Turk J Haematol. 2008 Jun 5;25(2):94-7. English. PMID: 27264447.

66: İlhan O, Topçuoğlu P, Arat M, Soydan EA, Yuksel MK, Arslan Ö, Özcan M, Gürman G, Demirer T, Akan H, Konuk N, Uysal A. Allogeneic hematopoietic stem cell transplantation (allo-HSCT) in acute myeloblastic leukemia (AML): A single center experience. Turk J Haematol. 2008 Jun 5;25(2):87-93. English. PMID: 27264446.

67: Yazman D, Konuk N, Ozcan M, Arat M, Soydan E, Arslan O, Ilhan O. A case report of the Modified Malmö Protocol: an alternative therapeutic approach to refractory chronic idiopathic thrombocytopenic purpura. Ther Apher Dial. 2008 Jun;12(3):255-8. doi: 10.1111/j.1744-9987.2008.00582.x. PMID: 18503705.

68: Bektas M, Idilman R, Soykan I, Soydan E, Arat M, Cinar K, Coban S, Tuzun A, Bozkaya H, Ormeci N, Ozden A. Adjuvant therapeutic plasma exchange in liver failure: assessments of clinical and laboratory parameters. J Clin Gastroenterol. 2008 May-Jun;42(5):517-21. doi: 10.1097/MCG.0b013e31815878ff. PMID: 18344887.

69: Topçuoğlu P, Bakanay ŞM, Dalva K, Arat M, Beksaç M, Özcan M. T-helper-1 (Th1) and Th2 cytokines after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Turk J Haematol. 2008 Mar 5;25(1):24-35. English. PMID: 27264147.

70: Sanli H, Akay BN, Arat M, Koçyigit P, Akan H, Beksac M, Ilhan O. Vitiligo after hematopoietic cell transplantation: six cases and review of the literature. Dermatology. 2008;216(4):349-54. doi: 10.1159/000117705. Epub 2008 Feb 20. PMID: 18285686.

71: Gratwohl A, Baldomero H, Frauendorfer K, Rocha V, Apperley J, Niederwieser D; Joint Accreditation Committee of the International Society for Cellular Therapy (ISCT); European Group for Blood and Marrow Transplantation EBMT (JACIE). The EBMT activity survey 2006 on hematopoietic stem cell transplantation: focus on the use of cord blood products. Bone Marrow Transplant. 2008 Apr;41(8):687-705. doi: 10.1038/sj.bmt.1705956. Epub 2007 Dec 17. PMID: 18084334.

72: Arslan O, Arat M. Apheresis information management system (AMIS). Transfus Apher Sci. 2007 Jun;36(3):281-3. doi: 10.1016/j.transci.2007.03.009. Epub 2007 Jun 28. PMID: 17604695.

73: Soydan E, Ayyildiz E, Dalva K, Topçuoğlu P, Tol M, Arslan O, Ilhan O, Arat M. Impact of harvest product volume in erythrocyte depletion of allogeneic or autologous bone marrow using COBE spectra. Transfus Apher Sci. 2007 Jun;36(3):269-73. doi: 10.1016/j.transci.2007.03.006. Epub 2007 Jun 15. PMID: 17574924.

74: Topcuoglu P, Akcaglayan Soydan E, Ekiz F, Ayyildiz E, Dalva K, Ozcan M, Arslan O, Arat M, Ilhan O. How to calculate the quantity of CD34+ cells infused? A single center cohort study based on actual, ideal or adjusted ideal body weight. Transfus Apher Sci. 2007 Jun;36(3):275-80. doi: 10.1016/j.transci.2007.03.007. Epub 2007 Jun 13. PMID: 17569588.

75: Arat M. Selected papers from the 15th Congress of the Interdisciplinary European Society for Hemapheresis and Hemotherapy. Transfus Apher Sci. 2007 Jun;36(3):259-60. doi: 10.1016/j.transci.2007.03.003. Epub 2007 Jun 6. PMID: 17556021.

76: Büyükkağnici DI, Ilhan O, Kavas GO, Arslan O, Arat M, Dalva K, Ayyildiz E. Effects of plasma nitric oxide levels on platelet activation in single donor apheresis and random donor concentrates. Transfus Apher Sci. 2007 Feb;36(1):73-8. doi: 10.1016/j.transci.2006.05.016. Epub 2007 Jan 22. PMID: 17236811.

77: Ayyildiz E, Arslan O, Topçuoğlu P, Arat M, Dalva K, Soydan EA, Tol M, Ilhan O. The effect of extracorporeal photoimmunotherapy (ECP) on serum TNF-a level in chronic graft versus host disease (GvHD). Transfus Apher Sci. 2007 Feb;36(1):79-85. doi: 10.1016/j.transci.2006.06.007. Epub 2007 Jan 17. PMID: 17234454.

78: Yücesan C, Arslan O, Arat M, Yücemen N, Ayyildiz E, Ilhan O, Mutluer N. Therapeutic plasma exchange in the treatment of neuroimmunologic disorders: review of 50 cases. Transfus Apher Sci. 2007 Feb;36(1):103-7. doi: 10.1016/j.transci.2006.06.008. Epub 2007 Jan 16. PMID: 17224307.

79: Parlak M, Sancak T, Arat M, Bilgiç S, Sanlidilek U. Tunneled catheters placed in bone marrow transplant patients: radiological and clinical follow-up results. Diagn Interv Radiol. 2006 Dec;12(4):190-4. PMID: 17160804.

80: Durdu S, Akar AR, Arat M, Sancak T, Eren NT, Ozyurda U. Autologous bone- marrow mononuclear cell implantation for patients with Rutherford grade II-III thromboangiitis obliterans. J Vasc Surg. 2006 Oct;44(4):732-9. doi: 10.1016/j.jvs.2006.06.023. Epub 2006 Aug 22. PMID: 16926085.

81: Bakanay SM, Dalva K, Arat M, Arslan O, Ayyildiz E, Beksac M, Ilhan O. Does continuous flow apheresis influence viability in allogeneic hematopoietic stem cell harvest? Transfus Apher Sci. 2006 Apr;34(2):171-8. doi: 10.1016/j.transci.2005.12.006. Epub 2006 Mar 20. PMID: 16545614.

82: Coşkun HŞ, İlhan O, Özcan M, Ayaz S, Dalva K, Üstün C, Arat M. Serum transforming growth factor beta 1 levels in multiple myeloma patients. Turk J Haematol. 2006 Mar 5;23(1):47-52. English. PMID: 27265228.

83: Arat M, Idilman R, Soydan EA, Soykan I, Erden E, Karayalçin S, Akan H. Ursodeoxycholic acid treatment in isolated chronic graft-vs.-host disease of the liver. Clin Transplant. 2005 Dec;19(6):798-803. doi: 10.1111/j.1399-0012.2005.00424.x. PMID: 16313328.

84: Idilman R, Kuzu I, Erden E, Arat M, Soydan E, Soykan I, Akyol G, Karayalcin S, Akan H, Beksac M. Evaluation of the effect of transplant-related factors and tissue injury on donor-derived hepatocyte and gastrointestinal epithelial cell repopulation following hematopoietic cell transplantation. Bone Marrow Transplant. 2006 Jan;37(2):199-206. doi: 10.1038/sj.bmt.1705214. PMID: 16299546.

85: Idilman R, Erden E, Arat M, Soydan E, Erkan O, Kuzu I, Sahin Y, Coban S, Bozdayi M, Giraud A, Akan H, Karayalcin S, Ozden A. Trefoil factor expression in biliary epithelium of graft-versus-host disease of the liver after allogeneic hematopoietic cell transplantation. Transplantation. 2005 Oct 27;80(8):1099-104. doi: 10.1097/01.tp.0000179151.55881.a7. PMID: 16278592.

86: Azap A, Topçuoğlu P, Yeşilkaya A, Arat M, Memikoğlu O, Akan Ö, Kurt H, Tekeli E, Akan H. The effect of a nationwide antibiotic restriction policy on antibiotic usage in a stem cell transplantation unit. Turk J Haematol. 2005 Jun 5;22(2):87-90. English. PMID: 27264666.

87: Tek I, Arslan O, Arat M, Ayyildiz E, Tol M, Oral M, Ilhan O. Effects of replacement fluids used for therapeutic plasma exchange on plasma viscosity and plasma oncotic pressure. Transfus Apher Sci. 2004 Oct;31(2):89-93. doi: 10.1016/j.transci.2004.02.010. PMID: 15501412.

88: Kuzu I, Beksac M, Arat M, Celebi H, Elhan AH, Erekul S. Bone marrow microvessel density (MVD) in adult acute myeloid leukemia (AML): therapy induced changes and effects on survival. Leuk Lymphoma. 2004 Jun;45(6):1185-90. doi: 10.1080/1042819032000159915. PMID: 15359999.

89: Demirer T, Ayli M, Fen T, Ozcan M, Arat M, Buyukberber S, Arslan O, Gurman G, Akan H, Ilhan O. High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation in patients with lymphoma -- a retrospective evaluation. Bone Marrow Transplant. 2004 Nov;34(9):781-6. doi: 10.1038/sj.bmt.1704672. PMID: 15354206.

90: Sanli H, Ekmekçi P, Arat M, Gürman G. Clinical manifestations of cutaneous graft-versus-host disease after allogeneic haematopoietic cell transplantation: long-term follow-up results in a single Turkish centre. Acta Derm Venereol. 2004;84(4):296-301. doi: 10.1080/00015550410025840. PMID: 15339075.

91: Arslan O, Tek I, Arat M, Ciftçi I, Ilhan O. Effects of replacement fluids on plasma viscosity used for therapeutic plasma exchange. Ther Apher Dial. 2004 Apr;8(2):144-7. doi: 10.1111/j.1526-0968.2003.00110.x. PMID: 15255128.

92: Arat M, Arslan O, Ayyildiz E, Topcuoglu P, Dalva K, Ilhan O. Peripheral blood stem cell apheresis for allogeneic transplants: Ibni Sina experience. Transfus Apher Sci. 2004 Jun;30(3):189-91. doi: 10.1016/j.transci.2004.02.004. PMID: 15172622.

93: Ilhan O, Arat M, Arslan O, Ayyildiz E, Sanli H, Beksac M, Ozcan M, Gürman G, Akan H. Extracorporeal photoimmunotherapy for the treatment of steroid refractory progressive chronic graft-versus-host disease. Transfus Apher Sci. 2004 Jun;30(3):185-7. doi: 10.1016/j.transci.2004.02.003. PMID: 15172621.

94: Arslan O, Arat M, Tek I, Ayyildiz E, Ilhan O. Therapeutic plasma exchange in a single center: Ibni Sina experience. Transfus Apher Sci. 2004 Jun;30(3):181-4. doi: 10.1016/j.transci.2004.02.007. PMID: 15172620.

95: Yildirim I, Ozer Y, Yüksel MK, Arat M, Arslan O. Erythrocyte antigen and reticulocyte engraftment after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2004 Aug;34(4):351-5. doi: 10.1038/sj.bmt.1704576. PMID: 15170158.

96: Arslan O, Toprak S, Arat M, Kayalak Y. Hb content-based transfusion policy successfully reduces the number of RBC units transfused. Transfusion. 2004 Apr;44(4):485-8. doi: 10.1111/j.1537-2995.2004.03225.x. PMID: 15043562.

97: Sanli H, Kusak F, Arat M, Ekmekci P, Ilhan O. Simultaneous onset of chronic graft versus host disease and alopecia areata following allogeneic haematopoietic cell transplantation. Acta Derm Venereol. 2004;84(1):86-7. doi: 10.1080/00015550310020594. PMID: 15040493.

98: Sanli H, Arat M, Oskay T, Gürman G. Evaluation of nail involvement in patients with chronic cutaneous graft versus host disease: a single-center study from Turkey. Int J Dermatol. 2004 Mar;43(3):176-80. doi: 10.1111/j.1365-4632.2004.01629.x. PMID: 15009386.

99: Akar R, Durdu S, Arat M, Eren NT, Arslan Ö, Çorapçıoğlu T, Sancak T, Uzun B, Kİr M, İlhan O, Özyurda Ü. Therapeutic Angiogenesis by Autologous Transplantation of Bone Marrow Mononuclear Cells for Buerger's Patients with Retractable Limb Ischaemia: A Preliminary Report. Turk J Haematol. 2004 Mar 5;21(1):13-21. English. PMID: 27263642.

100: Idilman R, Arat M, Soydan E, Törüner M, Soykan I, Akbulut H, Arslan O, Ozcan M, Türkyilmaz AR, Bozdayi M, Karayalçin S, Van Thiel DH, Ozden A, Beksaç M, Akan H. Lamivudine prophylaxis for prevention of chemotherapy-induced hepatitis B virus reactivation in hepatitis B virus carriers with malignancies. J Viral Hepat. 2004 Mar;11(2):141-7. doi: 10.1046/j.1365-2893.2003.00479.x. PMID: 14996349.

101: Arat M, Arslan O, Gürman G, Dalva K, Ozcan M, Uğur A, Ilhan O. The impact of granulocyte colony stimulating factor at content of donor lymphocytes collected for cellular immunotherapy. Transfus Apher Sci. 2004 Feb;30(1):9-15. doi: 10.1016/j.transci.2003.05.004. PMID: 14746816.

102: Kurt Yüksel M, Arat M, Arslan Ö, Beksaç M, İlhan O. Autologous Platelet Collection and Storage to Support Thrombocytopenia in a Leukemia Patient with Platelet Alloimmunization Undergoing Chemotherapy. Turk J Haematol. 2003 Dec 5;20(4):233-6. English. PMID: 27263520.

103: Topcuoglu P, Arat M, Dalva K, Ozcan M. Administration of granulocyte- colony-stimulating factor for allogeneic hematopoietic cell collection may induce the tissue factor-dependent pathway in healthy donors. Bone Marrow Transplant. 2004 Jan;33(2):171-6. doi: 10.1038/sj.bmt.1704341. PMID: 14647251.

104: Sanli H, Ekmekci P, Kusak F, Arat M, Beksaç M. Hyperkeratosis of the nipple associated with chronic graft versus host disease after allogeneic haematopoietic cell transplantation. Acta Derm Venereol. 2003;83(5):385-6. doi: 10.1080/00015550310012665. PMID: 14609115.

105: Sanli H, Anadolu R, Arat M, Ekmekci P, Birol A, Erdem C, Koç H. Dermatomal lichenoid graft-versus-host disease within herpes zoster scars. Int J Dermatol. 2003 Jul;42(7):562-4. doi: 10.1046/j.1365-4362.2003.01723_2.x. PMID: 12839612.

106: Demirer T, Uysal VA, Ayli M, Genc Y, Ilhan O, Koc H, Dagli M, Arat M, Gunel N, Fen T, Dincer S, Ustael N, Yildiz M, Ustun T, Seyrek E, Ozet G, Muftuoglu O, Akan H. High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous stem cell transplantation in patients with advanced breast cancer: a retrospective evaluation. Bone Marrow Transplant. 2003 May;31(9):755-61. doi: 10.1038/sj.bmt.1703918. PMID: 12732881.

107: Unal AE, Bayar S, Arat M, Ilhan O. Malpositioning of Hickman catheters, left versus right sided attempts. Transfus Apher Sci. 2003 Feb;28(1):9-12. doi: 10.1016/S1473-0502(02)00094-0. PMID: 12620263.

108: Tek I, Arslan O, Arat M, Ozcan M, Akdağ B, Ilhan O. Effects of replacement fluids on coagulation system used for therapeutic plasma exchange. Transfus Apher Sci. 2003 Feb;28(1):3-7. doi: 10.1016/S1473-0502(02)00093-9. PMID: 12620262.

109: Arslan Ö, Arat M, Göktürk S, Ayyıldız E, İlhan O. Therapeutic Plasma Exchange and the Clinical Applications. Turk J Haematol. 2003 Mar 5;20(1):7-17. PMID: 27265329.

110: Demirer T, Ilhan O, Ayli M, Arat M, Dagli M, Ozcan M, Haznedar R, Genc Y, Fen T, Ayyildiz E, Dincer S, Arslan O, Gurman G, Konuk N, Dalva K, Uysal A, Koc H, Ozet G, Akan H. Monitoring of peripheral blood CD34+ cell counts on the first day of apheresis is highly predictive for efficient CD34+ cell yield. Ther Apher. 2002 Oct;6(5):384-9. doi: 10.1046/j.1526-0968.2002.00406.x. PMID: 12423534.

111: Arslan Ö, Coşkun HŞ, Arat M, Soydan E, Özcan M, Gürman G, Çelebi H, Demirer T, Akan H, İlhan O, Konuk N, Uysal A, Berksaç M, Koç H. The Role of ABO Incompatibility in Allogeneic Peripheral Blood Stem Cell Transplant. Turk J Haematol. 2002 Sep 5;19(3):401-9. PMID: 27264977.

112: Bozkaya H, Yurdaydin C, Törüner M, Arat M, Bozdayi AM, Erekul S, Cinar K, Koç H, Uzunalimoğlu O. Remission of severe aplastic anemia associated with hepatitis B virus infection after viral clearance: potential role of lamivudine. Dig Dis Sci. 2002 Aug;47(8):1782-5. doi: 10.1023/a:1016444611997. PMID: 12184530.

113: Gürman G, Arat M, Ilhan O, Konuk N, Beksaç M, Celebi H, Ozcan M, Arslan O, Ustün C, Akan H, Uysal A, Koç H. Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies. Cytotherapy. 2001;3(4):253-60. doi: 10.1080/146532401317070880. PMID: 12171713.

114: Demirer T, Dagli M, Ilhan O, Ayli M, Haznedar R, Fen T, Gunel N, Genc Y, Arat M, Ozcan M, Arslan O, Seyrek E, Dincer S, Ustun T, Ustael N, Koc H, Muftuoglu O, Akan H. A randomized trial of assessment of efficacy of leukapheresis volumes, 8 liters vs 12 liters. Bone Marrow Transplant. 2002 Jun;29(11):893-7. doi: 10.1038/sj.bmt.1703571. PMID: 12080353.

115: Arslan O, Akan H, Arat M, Dalva K, Ozcan M, Gürman G, Ilhan O, Konuk N, Beksaç M, Uysal A, Koç H. Soluble adhesion molecules (sICAM-1, sL-Selectin, sE- Selectin, sCD44) in healthy allogenic peripheral stem-cell donors primed with recombinant G-CSF. Cytotherapy. 2000;2(4):259-65. doi: 10.1080/146532400539198. PMID: 12042035.

116: Arat M, Ulusoy V, Demirer T, Uysal AV, Ozcan M, Dinçer S, Ilhan O, Koç H. An unusual presentation of plasma cell dyscrasias: cardiac tamponade due to myelomatous infiltration. Leuk Lymphoma. 2002 Jan;43(1):145-8. doi: 10.1080/10428190210182. PMID: 11908719.

117: Arıkan Akan Ö, Bengisun JS, Batı A, Arat M, İlhan O, Akan H. A Case of Catheter Related Septicemia Caused by Corynebacterium jeikeium. Turk J Haematol. 2002 Mar 5;19(1):47-50. PMID: 27264626.

118: Demirer T, Ilhan O, Arat M, Genç Y, Ozcan M, Dalva K, Celebi H, Beksaç M, Akan H, Gürman G, Konuk N, Uysal A, Arslan O, Koç H. CD41+ and CD42+ hematopoietic progenitor cells may predict platelet engraftment after allogeneic peripheral blood stem cell transplantation. J Clin Apher. 2001;16(2):67-73. doi: 10.1002/jca.1015. PMID: 11746531.

119: Ustün C, Arat M, Celebi H, Akan H, Ilhan O, Ozçelik T, Burgess RE, Koc H. Extramedullary relapse following allogeneic stem cell transplantation in acute promyelocytic leukemia: the role of ATRA. Haematologica. 2001 Oct;86(10):E31. PMID: 11602438.

120: Arat M, Köklü A, Ozdiler E, Rübendüz M, Erdoğan B. Craniofacial growth and skeletal maturation: a mixed longitudinal study. Eur J Orthod. 2001 Aug;23(4):355-61. doi: 10.1093/ejo/23.4.355. PMID: 11544785.

121: Gürman G, Dilek I, Arslan O, Arat M, Beksaç M, Ilhan O, Ozcan M, Akan H, Dalva K, Konuk N, Uysal A, Koç H. The effect of G-CSF on lymphocyte subsets and CD34+ cells in allogeneic stem cell transplantation. Transfus Apher Sci. 2001 Feb;24(1):23-8. doi: 10.1016/s0955-3886(00)00123-5. PMID: 11515607.

122: Arat M, Ilhan O, Iayan EA, Celebi H, Koç H, Akan H. Treatment of extensive chronic sclerodermatous graft-versus-host disease with high-dose immunosuppressive therapy and CD34+ autologous stem cell rescue. Blood. 2001 Aug 1;98(3):892-3. doi: 10.1182/blood.v98.3.892. PMID: 11482319.

123: Beksac M, Ma M, Akyerli C, DerDanielian M, Zhang L, Liu J, Arat M, Konuk N, Koc H, Ozcelik T, Vescio R, Berenson JR. Frequent demonstration of human herpesvirus 8 (HHV-8) in bone marrow biopsy samples from Turkish patients with multiple myeloma (MM). Leukemia. 2001 Aug;15(8):1268-73. doi: 10.1038/sj.leu.2402190. PMID: 11480570.

124: Arat M, Arslan O, Beksaç M, Keven K, Nergizoğlu G, Ertürk S. Hematopoietic cell transplantation-related nephropathy. Am J Kidney Dis. 2001 Jul;38(1):218-9. doi: 10.1053/ajkd.2001.26163. PMID: 11431209.

125: Ozcan M, Ustün C, Akçağlayan E, Akan H, Arslan O, Ilhan O, Beksaç M, Gürman G, Demirer T, Arat M, Celebi H, Konuk N, Uysal A, Koç H. Recombinant human granulocyte colony-stimulating factor (rh-G-CSF) may accelerate hematopoietic recovery after HLA-identical sibling allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant. 2001 Mar;27(5):499-505. doi: 10.1038/sj.bmt.1702816. PMID: 11313683.

126: Gürman G, Celebi H, Ustün C, Arat M, Ilhan O, Ozcan M, Arslan O, Uysal A, Akan H, Beksaç M, Konuk N, Koç H. Allogeneic peripheral blood stem cell transplantation for severe aplastic anemia. Ther Apher. 2001 Feb;5(1):54-7. doi: 10.1046/j.1526-0968.2001.005001054.x. PMID: 11258612.

127: Beksaç M, Arat M, Akan H, Koç H, Ilhan O, Ozcan M. Circulating CD44 and intercellular adhesion molecule-1 levels in low grade non-hodgkin lymphoma and B-cell chronic lymphocytic leukemia patients during interferon-alpha-2a treatment. Cancer. 2000 Oct 1;89(7):1474-81. PMID: 11013360.

128: Akan H, Güven N, Aydogdu I, Arat M, Beksaç M, Dalva K. Thrombopoietic cytokines in patients with iron deficiency anemia with or without thrombocytosis. Acta Haematol. 2000;103(3):152-6. doi: 10.1159/000041038. PMID: 10940653.

129: Celebi H, Akan H, Akçağlayan E, Ustün C, Arat M. Febrile neutropenia in allogeneic and autologous peripheral blood stem cell transplantation and conventional chemotherapy for malignancies. Bone Marrow Transplant. 2000 Jul;26(2):211-4. doi: 10.1038/sj.bmt.1702503. PMID: 10918433.

130: Gökalp H, Arat M, Erden I. The changes in temporomandibular joint disc position and configuration in early orthognathic treatment: a magnetic resonance imaging evaluation. Eur J Orthod. 2000 Jun;22(3):217-24. doi: 10.1093/ejo/22.3.217. PMID: 10920553.

131: Arslan O, Coşkun H, Arat M, Celebi H, Ozcan M, Gürman G, Ustün C, Demirer T, Akan H, Ilhan O, Konuk N, Beksaç M, Uysal A, Koç H. Allogeneic peripheral blood stem cell transplantation for standard risk leukemia: experience of Ibni Sina Hospital. Bone Marrow Transplant. 2000 Jun;25(12):1229-32. doi: 10.1038/sj.bmt.1702414. PMID: 10871726.

132: Çelebi H, Üstün C, Arat M, Akan H, Tunçman G, Özçelik T, Coşkun HŞ, Koç H. An Extra Benefit of Allogeneic Peripheral Blood Stem Cell Transplantation in a Patient with Lymphoblastic Lymphoma: Cure of Thalassemia Minor. Turk J Haematol. 2000 Jun 5;16(4):77-9. PMID: 27265858.

133: İdilman R, Üstün C, Aslan Ö, Özcan M, Arat M, Bozkaya H, Bozdayı M, Şengezer T, Uzunalimoğlu Ö, Dökmeci A, İlhan O, Koç H, Akan H. The Incidence of Hepatitis G Virus in Patients with Hematological Malignancies: The Relationship to the Number of Blood and Blood Products Transfusions. Turk J Haematol. 2000 Jun 5;16(4):67-71. PMID: 27265856.

134: Ilhan O, Uskent N, Arslan O, Arat M, Ozkalemkaş F, Oztürk G, Kalayoglu SB, Ozet A, Tombuloglu M, Arpaci F, Ovali E, Anak S. National survey of hemapheresis practice in Turkey (1998). Transfus Sci. 2000 Jun;22(3):195-201. doi: 10.1016/s0955-3886(00)00057-6. PMID: 10831922.

135: Demirer T, Ilhan O, Mandel NM, Arat M, Günel N, Celebi H, Ustün C, Akan H, Demirer S, Aydintuğ S, Uysal A, Koç H. A phase I dose escalation study of high- dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation (PBSCT) in patients with solid tumors and hematologic malignancies. Bone Marrow Transplant. 2000 Apr;25(7):697-703. doi: 10.1038/sj.bmt.1702239. PMID: 10745253.

136: Ilhan O, Arslan O, Arat M, Beksaç M, Akan H, Ozcan M, Gürman G, Konuk N, Uysal A, Koç H. The impact of the CD34+ cell dose on engraftment in allogeneic peripheral blood stem cell transplantation. Transfus Sci. 1999 Feb;20(1):69-71. doi: 10.1016/s0955-3886(98)00094-0. PMID: 10621563.

137: Ustün C, Ozcan M, Gürman G, Cakir M, Erekul S, Akyol G, Arat M, Celebi H, Idlman R, Ilhan O, Demirer T, Beksac M, Koc H. Differences in liver pathology and clinical outcome between two patients with hepatitis B virus and graft versus host disease. Pathol Oncol Res. 1999;5(3):229-32. doi: 10.1053/paor.1999.0229. PMID: 10491023.

138: Demirer T, Celebi H, Arat M, Ustün C, Demirer S, Dilek I, Ozcan M, Ilhan O, Akan H, Gürman G, Koç H. Autoimmune thrombocytopenia in a patient with small cell lung cancer developing after chemotherapy and resolving following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant. 1999 Aug;24(3):335-7. doi: 10.1038/sj.bmt.1701902. PMID: 10455376.

139: Ustün C, Celebi H, Arat M, Ozcan M, Dilek I, Gürman G, Demirer T, Ilhan O, Keskin R, Koç H. Treatment of aregeneratoric anemia following an ABO- incompatible allogeneic peripheral blood stem cell transplantation: a case report. Ther Apher. 1999 Aug;3(3):275-7. doi: 10.1046/j.1526-0968.1999.00135.x. PMID: 10427629.

140: Arslan O, Ustün C, Arat M, Celebi H, Akan H, Beksaç M, Ilhan O, Gürman G, Ozcan M, Konuk N, Uysal A, Koç H. Allogeneic peripheral blood stem cell transplantation in acute non-lymphoblastic leukemia. Hematol Oncol. 1998 Dec;16(4):155-62. doi: 10.1002/(sici)1099-1069(199812)16:4<155::aid- hon633>3.0.co;2-0. PMID: 10414235.

141: Ustün C, Arslan O, Beksaç M, Koç H, Gürman G, Ozçelik T, Yilmaz B, Ilhan O, Akan H, Ozcan M, Demirer T, Uysal A, Konuk N, Arat M, Dilek I, Celebi H, Coskun HS. A retrospective comparison of allogeneic peripheral blood stem cell and bone marrow transplantation results from a single center: a focus on the incidence of graft-vs.-host disease and relapse. Biol Blood Marrow Transplant. 1999;5(1):28-35. doi: 10.1053/bbmt.1999.v5.pm10232738. PMID: 10232738.

142: Beksaç M, Arat M, Idilman R. Long term follow-up and late complications of 2-chlorodeoxyadenosine in previously treated, advanced, indolent non-Hodgkin's lymphoma. Cancer. 1999 Jan 1;85(1):242-3. doi: 10.1002/(sici)1097-0142(19990101)85:1<242::aid-cncr34>3.0.co;2-r. PMID: 9921999.

143: Beksaç M, Arslan O, Koç H, Akan H, Ilhan O, Arat M, Ozcan M, Gürman G, Konuk N, Uysal A. Randomised unicenter trial for comparison of three regimens in de novo adult acute nonlymphoblastic leukaemia. Med Oncol. 1998 Sep;15(3):183-90. doi: 10.1007/BF02821937. PMID: 9819795.

144: Dilek I, Demirer T, Ustün C, Arat M, Koç H, Beksaç M, Erdi H, Anadolu R, Ozcan M, Ilhan O, Akan H. Acquired ichthyosis associated with chronic graft- versus-host disease following allogeneic peripheral blood stem cell transplantation in a patient with chronic myelogenous leukemia. Bone Marrow Transplant. 1998 Jun;21(11):1159-61. doi: 10.1038/sj.bmt.1701240. PMID: 9645582.

145: Koç H, Arslan O, Gürman G, Akan H, Ozcan M, Ilhan O, Aydoğdu I, Arat M, Beksaç M, Konuk N, Uysal A. Use of high-dose chemotherapy plus granulocyte colony-stimulating factor for the salvage of refractory or resistant-relapse lymphoma patients without stem cell support. Acta Haematol. 1997;98(3):136-9. doi: 10.1159/000203607. PMID: 9352743.